Stock Earnings

Question 1

What are Medexus Pharmaceuticals Inc.'s key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Medexus Pharmaceuticals Inc. has a total asset of $171, Net profit of $2

Question 2

What are the key financial ratios for MEDXF?

Accepted Answer

Medexus Pharmaceuticals Inc.'s Current ratio is 1.43, has a Net margin is 1.85, sales per share of $4.07.

Question 3

How is Medexus Pharmaceuticals Inc.'s revenue broken down by segment or geography?

Accepted Answer

Medexus Pharmaceuticals Inc. largest revenue segment is Offline Advertising and Web Banner, at a revenue of 2,887,814 in the most earnings release.For geography, Hong Kong is the primary market for Medexus Pharmaceuticals Inc., at a revenue of 5,195,844.

Question 4

Is Medexus Pharmaceuticals Inc. profitable?

Accepted Answer

yes, according to the latest financial statements, Medexus Pharmaceuticals Inc. has a net profit of $2

Question 5

Does Medexus Pharmaceuticals Inc. have any liabilities?

Accepted Answer

yes, Medexus Pharmaceuticals Inc. has liability of 119

Question 6

How many outstanding shares for Medexus Pharmaceuticals Inc.?

Accepted Answer

Medexus Pharmaceuticals Inc. has a total outstanding shares of 32.25

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	104	108	113	108	76	79
Revenue Growth (YoY)	0%	-4%	5%	42%	-4%	7%
Cost of Revenue	48	51	53	48	38	37
Gross Profit	55	56	59	60	37	42
Selling, General & Admin	47	43	44	48	44	36
Research & Development	1	1	1	2	5	4
Operating Expenses	49	44	46	51	50	42
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	0	1	0	-5	-3	-31
Income Tax Expense	0	0	0	-6	0	-3
Net Income	0	2	0	1	-2	-28
Net Income Growth	-100%	--	-100%	-150%	-93%	367%
Shares Outstanding (Diluted)	32.28	26.5	22.32	20.52	19.45	15.2
Shares Change (YoY)	32%	19%	9%	6%	28%	6%
EPS (Diluted)	0.01	0.08	0	0.05	-0.14	-1.86
EPS Growth	-82%	-983%	-115.99%	-140%	-92%	333%
Free Cash Flow	13	21	18	-1	-8	-5
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	52.88%	51.85%	52.21%	55.55%	48.68%	53.16%
Operating Margin	4.8%	10.18%	10.61%	7.4%	-15.78%	0%
Profit Margin	0%	1.85%	0%	0.92%	-2.63%	-35.44%
Free Cash Flow Margin	12.5%	19.44%	15.92%	-0.92%	-10.52%	-6.32%
EBITDA	5	18	17	14	-6	5
EBITDA Margin	4.8%	16.66%	15.04%	12.96%	-7.89%	6.32%
D&A For EBITDA	0	7	5	6	6	5
EBIT	5	11	12	8	-12	0
EBIT Margin	4.8%	10.18%	10.61%	7.4%	-15.78%	0%
Effective Tax Rate	0%	0%	0%	120%	0%	9.67%

Medexus Pharmaceuticals Inc. (MEDXF) Price

MEDXF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

EPS (TTM)

Dividend yield

Market Cap

What is Medexus Pharmaceuticals Inc?

MEDXF Income

Follow-Up Questions